ERBB2 and breast carcinoma: In the treatment of HER2-positive breast cancer, blocking HER2 signaling pathway is a successful approach.893,894 A new strategy is to use HER2 N-glycan nanomolecular imprinted polymer (nano MIP) to effectively adhere to almost all HER2 polysaccharides.